Novartis spend on digital and data ‘in the 100s of millions’
In its annual results briefing in Basel, Switzerland, Novartis emphasised the integration of digital and data into the way the company works, claiming to be spending ‘in the 100s of millions’ on collating its ‘goldmine’ of more than two million patient years of clinical trial data.
Read More
